Views & Analysis Demonstrating value – the future for market access With the US joining other countries around the world in demanding definitions and measurements of the value of treatments, the pharma industry faces the challenge of understanding the requireme
Views & Analysis Utilise medtech for optimum care management Medtech companies can provide the tools to empower patients and HCPs.
Views & Analysis Healthcare’s hype cycle: which technologies will stay the co... Where should pharma invest to remain at the forefront of healthcare?
Views & Analysis 10 trends shaping pharma's future New technologies coming along to disrupt the pharma industry.
Views & Analysis UK funding of cancer drugs: right, wrong, or just plain conf... How do the countries of the UK fund cancer drugs today, and do they have the right approaches?
Views & Analysis Immunotherapies in oncology: the future of cancer treatment ... Partnerships, co-marketing and the positioning of drugs are shaping the competitive landscape in oncology.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.